Insufficient scRNA-seq data for expression of AMER1 at single-cell level.
Insufficient scRNA-seq data for expression of AMER1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 695.35 | 966 / 966 | 98% | 5.47 | 519 / 527 |
ovary | 100% | 1575.90 | 180 / 180 | 98% | 5.71 | 421 / 430 |
uterus | 100% | 853.85 | 170 / 170 | 98% | 5.05 | 449 / 459 |
prostate | 100% | 633.23 | 245 / 245 | 98% | 3.42 | 491 / 502 |
esophagus | 100% | 825.09 | 1444 / 1445 | 98% | 6.82 | 179 / 183 |
breast | 100% | 407.79 | 458 / 459 | 98% | 5.22 | 1092 / 1118 |
stomach | 100% | 672.89 | 359 / 359 | 97% | 6.46 | 278 / 286 |
pancreas | 100% | 587.80 | 328 / 328 | 97% | 3.25 | 173 / 178 |
lung | 99% | 444.04 | 573 / 578 | 98% | 5.16 | 1131 / 1155 |
bladder | 100% | 666.76 | 21 / 21 | 96% | 4.19 | 482 / 504 |
skin | 100% | 578.86 | 1808 / 1809 | 95% | 3.95 | 447 / 472 |
thymus | 100% | 535.96 | 653 / 653 | 94% | 2.85 | 571 / 605 |
brain | 94% | 402.51 | 2485 / 2642 | 97% | 3.30 | 685 / 705 |
adrenal gland | 100% | 468.32 | 257 / 258 | 91% | 3.58 | 210 / 230 |
kidney | 100% | 470.18 | 89 / 89 | 91% | 2.98 | 816 / 901 |
liver | 99% | 595.27 | 224 / 226 | 78% | 2.80 | 318 / 406 |
blood vessel | 100% | 687.27 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 952.01 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 547.68 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 5.71 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.65 | 1 / 1 |
adipose | 100% | 397.02 | 1198 / 1204 | 0% | 0 | 0 / 0 |
heart | 94% | 388.90 | 809 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 86% | 1.87 | 69 / 80 |
lymph node | 0% | 0 | 0 / 0 | 86% | 3.62 | 25 / 29 |
peripheral blood | 41% | 328.35 | 377 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045732 | Biological process | positive regulation of protein catabolic process |
GO_0031398 | Biological process | positive regulation of protein ubiquitination |
GO_0016055 | Biological process | Wnt signaling pathway |
GO_0060348 | Biological process | bone development |
GO_0090263 | Biological process | positive regulation of canonical Wnt signaling pathway |
GO_0060828 | Biological process | regulation of canonical Wnt signaling pathway |
GO_0072161 | Biological process | mesenchymal cell differentiation involved in kidney development |
GO_0090090 | Biological process | negative regulation of canonical Wnt signaling pathway |
GO_0060612 | Biological process | adipose tissue development |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0016604 | Cellular component | nuclear body |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0005546 | Molecular function | phosphatidylinositol-4,5-bisphosphate binding |
GO_1904713 | Molecular function | beta-catenin destruction complex binding |
GO_0008013 | Molecular function | beta-catenin binding |
GO_0005515 | Molecular function | protein binding |
Gene name | AMER1 |
Protein name | APC membrane recruitment protein 1 (Amer1) (Protein FAM123B) (Wilms tumor gene on the X chromosome protein) |
Synonyms | WTX FAM123B |
Description | FUNCTION: Regulator of the canonical Wnt signaling pathway. Acts by specifically binding phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2), translocating to the cell membrane and interacting with key regulators of the canonical Wnt signaling pathway, such as components of the beta-catenin destruction complex. Acts both as a positive and negative regulator of the Wnt signaling pathway, depending on the context: acts as a positive regulator by promoting LRP6 phosphorylation. Also acts as a negative regulator by acting as a scaffold protein for the beta-catenin destruction complex and promoting stabilization of Axin at the cell membrane. Promotes CTNNB1 ubiquitination and degradation. Involved in kidney development. . |
Accessions | ENST00000374869.8 [Q5JTC6-1] Q5JTC6 |